Estee Lauder forecasts profit below estimates, warns of $100 million tariff hit

Estee Lauder (EL.N) shares declined approximately 4% after the company forecast annual profit below analyst estimates, citing a $100 million tariff impact and a significant 13% drop in Q4 organic net sales amid weakness in key markets and muted travel retail. The luxury cosmetics firm reported a wider quarterly loss of $546 million and is implementing mitigation strategies, including inventory cuts, shifting production sourcing for China, and accelerating new launches, while also anticipating $1.2-$1.6 billion in restructuring charges by 2026. This performance underscores the ongoing pressures on the beauty sector from trade policy volatility and dampened consumer demand.

Analysis

Estee Lauder's (EL) shares declined approximately 4% following the release of its annual profit forecast, which fell short of analyst estimates. The company explicitly attributed this weakness to a projected $100 million negative impact from tariffs, guiding for a full-year adjusted EPS in the range of $1.90 to $2.10, below the LSEG consensus of $2.21. This guidance is underpinned by a significant deterioration in recent performance, evidenced by a 13% drop in fourth-quarter organic net sales, a sharp reversal from the 8% growth recorded a year prior. The sales decline was broad-based, with softness in key skincare and makeup segments, weakness in major markets including the U.S., China, France, and Germany, and continued muted performance in travel retail, which accounted for two-thirds of the quarter's 8% total sales drop. Financially, the company's quarterly loss widened to $546 million from $284 million a year ago, exacerbated by impairment charges on its Too Faced and Dr.Jart+ brands. In response, management is implementing several strategic shifts, including cutting inventory, reducing promotions, and altering its supply chain to source China-bound products from Japan and Europe instead of the U.S. to mitigate tariff impacts. However, investors must also price in significant future costs, as the company anticipates pre-tax restructuring charges between $1.2 billion and $1.6 billion by 2026.

Key Decisions for Investors

• Given the weak forward guidance, deteriorating sales momentum, and substantial restructuring charges on the horizon, investors should exercise caution as near-term headwinds are significant.
• Monitor key performance indicators for a potential turnaround, specifically looking for stabilization in organic sales growth in the U.S. and China, a recovery in the travel retail channel, and early signs of success from the new CEO's product launch and pricing strategies.
• Investors should adjust valuation models to account for the margin pressure from tariffs and the hefty $1.2 billion to $1.6 billion in restructuring costs, which will likely weigh on profitability and cash flow through 2026.